Medical News

RSS

Gleevec shows great promise in preventing cancer recurrence

Gleevec, a pill developed in conjunction with the Oregon Health & Science University Cancer Institute is again showing excellent results in preventing a cancer recurrence.

15 Apr 2007

A report for the ten year strategy for the reduction of vitamin and mineral deficiencies

A new report by AED Center for Nutrition and the Global Alliance for Improved Nutrition (GAIN) for the Food and Nutrition Bulletin shows that while cost-effective interventions to reduce vitamin and mineral deficiencies have existed for more than 20 years, significant micronutrient deficiencies still plague many countries, increasing maternal and child mortality and slowing brain development in children.

15 Apr 2007

Eradicating polio a better option than extended control of the disease

Concerns about the high perceived costs of eradicating the relatively low number of polio cases worldwide have led to recent suggestions that it is time to shift from a goal of eradication to control—abandoning eradication and allowing wild poliovirus to continue to circulate, which proponents of control believe can sustain the low number of cases.

15 Apr 2007

Transplant patients suffering from anemia have a greater mortality rate

According to a new study in American Journal of Transplantation, kidney transplant patients suffering from anemia, a treatable blood deficiency, are more likely to die or suffer from organ failure than other transplant recipients.

15 Apr 2007

Use of computer-assisted drug design in drug discovery

Metabasis Therapeutics has announced that on March 27, 2007 at the American Chemical Society 233rd National Meeting and Exposition in Chicago, Dr. M. Rami Reddy presented, "Use of Computer-Assisted Drug Design in Drug Discovery: Limitations and Advantages of Available Computational Methods."

15 Apr 2007

Nationwide survey of state Medicaid programs on "pay-for-performance" practices

In the first published nationwide survey of state Medicaid programs on “pay-for-performance” practices, more than half of all programs state that they provide financial incentives to health care providers for better quality care.

15 Apr 2007

People with two copies of a particular gene have a 70% higher risk of being obese

Scientists have identified the most clear genetic link yet to obesity in the general population as part of a major study of diseases funded by the Wellcome Trust, the UK's largest medical research charity.

15 Apr 2007

Macaque genome analysis will improve scientists' ability to identify human genes involved in diseases

Cornell experts in computational biology and bioinformatics have made key contributions to the analysis of the genome of the rhesus macaque, better known as the rhesus monkey.

15 Apr 2007

Lupin Pharmaceuticals receives FDA approval for Suprax

Lupin Pharmaceuticals has announced that the U.S. Food and Drug Administration (US FDA) has approved the company's application for Suprax (Cefixime for oral suspension 200mg/5ml).

15 Apr 2007

Low serum testosterone levels independently associated with fall risk in elderly men

Prolonged hypogonadism may result in erectile dysfunction, decreased libido, anemia, sarcopenia, memory loss, bone mineral loss, and the metabolic syndrome.

15 Apr 2007

Lower educational level makes some men more vulnerable to the effects of prostate cancer

Among men who have received similar treatments for prostate cancer, those with less education , particularly those who did not graduate from high school , experience a significant drop in their quality of life after treatment compared with men who have more education, according to a study led by researchers at the San Francisco VA Medical Center (SFVAMC).

15 Apr 2007

Seeing a person's face makes it easier to hear them

Experience hearing a person's voice allows us to more easily hear what they are saying. Now research by UC Riverside psychology Professor Lawrence D.

15 Apr 2007

Link between immune system and high plasma lipid levels

Researchers at the University of Chicago have found an unsuspected link between the immune system and high plasma lipid levels (cholesterol and triglycerides in the blood) in mice.

15 Apr 2007

Visual prosthesis

When the idea appeared several years ago, it sounded persuasive: How about implanting electrodes at the defective retina of blind subjects and connecting them with a mini camera in order to re-establish vision.

15 Apr 2007

Health insurers in California need to justify rates

Consumers enduring triple-digit health insurance increases will join Assemblyman Dave Jones (D-Sacramento) and consumer advocates to support Jones' legislation (AB 1554) requiring HMOs and health insurers to justify their rates and get approval for increases.

15 Apr 2007

Hands-on and minds-on approach to school science

In a paper to be presented Thursday, April 12, at the annual meeting of the American Educational Research Association, Ronna C.

15 Apr 2007

Intarcia Therapeutics announces results from study of injectable Omega Interferon plus Ribavirin for treatment of hepatitis C genotype-1

Intarcia Therapeutics has announced final results from a Phase 2 study of omega interferon with or without ribavirin in treatment-naive patients with genotype 1 chronic hepatitis C.

15 Apr 2007

New device increases circulation and blood flow to vital organs during CPR

In the United States, a person's chance of surviving cardiac arrest is probably much lower than most people realize: 17-19 percent in hospitals.

15 Apr 2007

New perspectives on risk taking in adolescence

While the government spends billions of dollars on educational and prevention programs to persuade teens not to do things like smoke, drink or do drugs, a Temple University psychologist suggests that competing systems within the brain make adolescents more susceptible to engaging in risky or dangerous behavior, and that educational interventions alone are unlikely to be effective.

15 Apr 2007

GlaxoSmithKline initiates study of PROMACTA in chronic idiopathic thrombocytopenic purpura

GlaxoSmithKline has announced the initiation of a global, open-label, single group trial that will assess the efficacy, safety and tolerability of PROMACTA (eltrombopag olamine) in patients previously treated for chronic idiopathic thrombocytopenic purpura (ITP).

15 Apr 2007